Detalhe da pesquisa
1.
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
N Engl J Med
; 388(1): 33-43, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546651
2.
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Invest New Drugs
; 42(1): 145-159, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324085
3.
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Br J Cancer
; 129(10): 1608-1618, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731023
4.
A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors.
Invest New Drugs
; 38(6): 1815-1825, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524319
5.
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Invest New Drugs
; 42(3): 340-341, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767685
6.
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Blood
; 128(14): 1821-1828, 2016 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531679
7.
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
Oncology
; 91(1): 48-54, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256106
8.
Patients' perceptions of research biopsies in phase I oncology trials.
Oncology
; 88(2): 95-102, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25322682
9.
Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers.
Int J Cancer
; 135(4): 996-1001, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497322
10.
Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
J Immunother Cancer
; 12(4)2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642937
11.
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 30(8): 1488-1500, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300720
12.
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
PLoS Med
; 10(11): e1001551, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265601
13.
ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study.
Oncogene
; 42(7): 541-544, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564469
14.
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study.
Dermatol Ther (Heidelb)
; 13(10): 2357-2373, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668898
15.
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634920
16.
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST).
Expert Opin Investig Drugs
; 31(9): 965-976, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107050
17.
Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors.
Diagnostics (Basel)
; 10(6)2020 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32575725
18.
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).
J Immunother Cancer
; 7(1): 46, 2019 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760319
19.
New molecular and immunotherapeutic approaches in biliary cancer.
ESMO Open
; 2(Suppl 1): e000152, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848675
20.
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 23(19): 5981-5992, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645941